107 related articles for article (PubMed ID: 15769948)
1. DNA methylation-related chromatin modification in the regulation of mouse delta-opioid receptor gene.
Wang G; Liu T; Wei LN; Law PY; Loh HH
Mol Pharmacol; 2005 Jun; 67(6):2032-9. PubMed ID: 15769948
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
Wang G; Wei LN; Loh HH
J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
[TBL] [Abstract][Full Text] [Related]
3. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
Zhang Y; Fatima N; Dufau ML
Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
[TBL] [Abstract][Full Text] [Related]
4. CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration.
Bhakat KK; Mitra S
Carcinogenesis; 2003 Aug; 24(8):1337-45. PubMed ID: 12807730
[TBL] [Abstract][Full Text] [Related]
5. The role of DNA methylation in setting up chromatin structure during development.
Hashimshony T; Zhang J; Keshet I; Bustin M; Cedar H
Nat Genet; 2003 Jun; 34(2):187-92. PubMed ID: 12740577
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
8. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.
Martinowich K; Hattori D; Wu H; Fouse S; He F; Hu Y; Fan G; Sun YE
Science; 2003 Oct; 302(5646):890-3. PubMed ID: 14593184
[TBL] [Abstract][Full Text] [Related]
10. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
12. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
[TBL] [Abstract][Full Text] [Related]
13. CpG methylation, chromatin structure and gene silencing-a three-way connection.
Razin A
EMBO J; 1998 Sep; 17(17):4905-8. PubMed ID: 9724627
[TBL] [Abstract][Full Text] [Related]
14. Induced epigenetic modifications of the promoter chromatin silence survivin and inhibit tumor growth.
Ma AN; Huang WL; Wu ZN; Hu JF; Li T; Zhou XJ; Wang YX
Biochem Biophys Res Commun; 2010 Mar; 393(4):592-7. PubMed ID: 20152814
[TBL] [Abstract][Full Text] [Related]
15. Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.
Merimi M; Klener P; Szynal M; Cleuter Y; Kerkhofs P; Burny A; Martiat P; Van den Broeke A
J Virol; 2007 Jun; 81(11):5929-39. PubMed ID: 17392371
[TBL] [Abstract][Full Text] [Related]
16. Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats.
Ke X; Lei Q; James SJ; Kelleher SL; Melnyk S; Jernigan S; Yu X; Wang L; Callaway CW; Gill G; Chan GM; Albertine KH; McKnight RA; Lane RH
Physiol Genomics; 2006 Mar; 25(1):16-28. PubMed ID: 16380407
[TBL] [Abstract][Full Text] [Related]
17. Treatment of tumor cells with histone deacetylase inhibitors results in altered recruitment of methyl-CpG binding proteins to a methylated CpG island.
Koizume S; Tachibana K; Shiraishi M
Biol Chem; 2003 May; 384(5):787-90. PubMed ID: 12817475
[TBL] [Abstract][Full Text] [Related]
18. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
[TBL] [Abstract][Full Text] [Related]
19. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter.
Astrand C; Belikov S; Wrange O
Exp Cell Res; 2009 Sep; 315(15):2604-15. PubMed ID: 19463811
[TBL] [Abstract][Full Text] [Related]
20. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
